Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 232,588,776 papers from all fields of science
Search
Sign In
Create Free Account
Poly-alendronate Dextran-Guanidine Conjugate
Known as:
Dextran/Alendronate/Guanidine-containing Polybisphosphonate
, ODX
A polybisphosphonate dextran-guanidine conjugate with potential anti-resorptive and antineoplastic activities. Alendronic acid and aminoguanidine…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
NCIt Antineoplastic Agent Terminology
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Impact of 21‐Gene Expression Assay on Staging Estrogen Receptor–Positive HER2‐Negative Breast Cancer
Andrea Breaux
,
B. Turner
,
+4 authors
M. Sanders
Clinical Breast Cancer
2019
Corpus ID: 54487482
2018
2018
Multigene Signature Panels and Breast Cancer Therapy: Patterns of Use and Impact on Clinical Decision Making.
N. Bhutiani
,
Michael E. Egger
,
N. Ajkay
,
C. Scoggins
,
Robert C. G. Martin
,
K. McMasters
Journal of the American College of Surgeons
2018
Corpus ID: 4323120
2018
2018
Prognostic Value of the Detection of Lymphovascular Invasion in Hormone Receptor-Positive Early Breast Cancer in the Era of Molecular Profiling
R. Mutai
,
H. Goldvaser
,
T. Shochat
,
I. Peretz
,
A. Sulkes
,
R. Yerushalmi
Oncology
2018
Corpus ID: 52823629
Background: Lymphovascular invasion (LVI) is considered a negative prognostic factor in early breast cancer, but its role in…
Expand
Review
2016
Review
2016
Influence of a 21-Gene Recurrence Score Assay on Chemotherapy Delivery in Breast Cancer.
C. Rutter
,
Xiaopan Yao
,
+7 authors
S. Evans
Clinical Breast Cancer
2016
Corpus ID: 22458539
2014
2014
Population-based evaluation of 21-gene assay in treatment decision making for early breast cancer in Ontario.
M. Levine
,
B. Cochrane
,
+4 authors
K. Pritchard
2014
Corpus ID: 78929337
583 Background: The OncotypeDX 21-gene assay (ODX) is used to aid in decision-making for chemotherapy (CT) in patients with…
Expand
2011
2011
P1-10-04: Cost-Utility of the 21-Gene Breast Cancer Assay (Oncotype DX®) in the Irish Healthcare Setting.
L. Lacey
,
R. Chien
,
J. Hornberger
2011
Corpus ID: 58582987
Objective: The Oncotype DX® Breast Cancer Test is a validated 21-gene assay that predicts the likelihood of benefit from adjuvant…
Expand
2011
2011
Treatment of bone metastasis in prostate cancer: efficacy of a novel polybisphosphonate.
F. Daubiné
,
R. Le Bot
,
M. Márquez
,
S. Nilsson
,
Torbjörn Schröder
,
A. Holmberg
Anticancer Research
2011
Corpus ID: 11502479
AIM To investigate the in vivo efficacy of a novel polybisphosphonate (ODX) in the treatment of bone metastasis from prostate…
Expand
Review
2007
Review
2007
How well do standard prognostic criteria predict oncotype DX (ODX) scores
A. Kamal
,
C. Loprinzi
,
+8 authors
M. Goetz
2007
Corpus ID: 74095660
576 Background: In node-negative, ER + breast cancer, gene expression profiling can identify level of risk and, in the case of…
Expand
2000
2000
Effect of Orchidectomy on the Age-Related Modulation of IL-1β and IL-1 Receptors following Lipopolysaccharide Treatment in the Mouse
W. Nanamiya
,
T. Takao
,
K. Asaba
,
Errol B. de Souza
,
Kozo Hashimoto
Neuroimmunomodulation
2000
Corpus ID: 7335603
Objective: To compare the effect of orchidectomy (ODX) in 7- and 24-week-old C57BL/6 mice on the age-related responses of the…
Expand
1995
1995
Repeated endotoxin treatment decreases immune and hypothalamo-pituitary-adrenal axis responses: effects of orchidectomy and testosterone therapy.
R. Hadid
,
E. Spinedi
,
Tatiana Daneva
,
G. Grau
,
R. Gaillard
Neuroendocrinology
1995
Corpus ID: 46786030
It is known that in vivo administration of bacterial endotoxin activates immune cells to release cytokines, these substances in…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE